Clinical Trial Management Systems Market 2019: Comprehensive Analysis by Top Key Companies, Industry Growth, Size, Share, Market Insights, Sales Volume and Forecast to 2024


The “Clinical Trial Management Systems Market” 2019 report provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries. Clinical Trial Management Systems Market report also aims to provide useful and comprehensive insights into current market trends and future growth scenarios. Clinical Trial Management Systems market report contains information like SWOT analysis, business highlights, strength, weakness, threats and opportunities of industry.

Top Manufacturers of Clinical Trial Management Systems Market Are:

  • Bioclinica
  • Bio
  • Optronics Inc.
  • DATATRAK International Inc.
  • ERT Clinical
  • IBM
  • Medidata Solutions Inc.
  • MedNet Solutions Inc.
  • Oracle
  • Parexel International Corporation
  • ArisGlobal

    Get a Sample Copy of the Report –

    Market Overview:

  • The clinical trial management systems market was valued at USD 665.90 million in 2017. Although the market has been in its nascent stage for the last five years, it has currently established itself as a mature market in the North American region. Asia-Pacific is still experiencing a high growth rate, when compared to other regions. This is mainly attributed to increasing clinical trials due to the high availability of inexpensive resources and increasing population pool in these regions. Moreover, the increased adoption of clinical trial management systems in the past few years has been a major factor that is contributing to the growth of this market.
  • Europe is expected to register a CAGR of 14.12%, as many Europeans regions are still in the process of adopting these systems. Many companies that have developed clinical trial management systems have found a way to integrate with the existing software providers, in order to provide an efficient workflow in clinical trial management.
  • The increasing innovative technological advancements to curb the increasing costs associated with clinical trials has resulted in the development of the clinical trials management system. Although these systems have not been completely adapted due to various factors, the increasing awareness and the need to cut down additional costs associated with clinical trials are expected to drive the market in the coming years. Increasing R&D and the rise in the number of clinical trials in the Asian region are expected to further contribute to the growth of the market studied, during the forecast period.

    Scope of the Report:

  • The clinical trial management systems market (henceforth, referred to as market studied’) is segmented on the basis of delivery mode, components, end user, and type of system. Based on delivery, the market is sub-segmented into web-based clinical trial management system, on-premise clinical trial management system, and cloud-based clinical trial management system. By component, the market is sub-segmented into software, hardware, and services. By end user, the market is sub-segmented into pharmaceuticals, contract research organizations, and other end users. Based on the type, the market is sub-segmented into site-based clinical trial management system and licensed enterprise-based clinical trial management system.

    Clinical Trial Management Systems Market Report Answers the Following Questions:

    • What will the market size and the growth rate be in 2024?
    • What are the key factors driving the global Clinical Trial Management Systems market?
    • What are the key market trends impacting the growth of the global Clinical Trial Management Systems market?
    • What are the challenges to market growth?
    • Who are the key vendors in the global Clinical Trial Management Systems market?
    • What are the market opportunities and threats faced by the vendors in the global Clinical Trial Management Systems market?
    • Trending factors influencing the market shares of the relevant regions.
    • What are the key outcomes of the five forces analysis of the global Clinical Trial Management Systems market?

    For More Information or Query or Customization Before Buying, Visit at –

    Key Market Trends:

    Cloud-based Clinical Trial Management Systems sub-segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

    Most big pharma and biotech companies are now increasingly adopting the cloud-based CTMS (clinical trial management systems). This increased adoption of cloud-based CTMS is because companies do not require to bear huge costs associated with the purchase of servers, and installation and validation of applications, and their maintenance. The new and advanced cloud-based CTMS facilitate the collaboration among the different groups at various sites to coordinate the successful completion of a trial.

    BSI (Business Systems Integration AG) provides CTMS solution as a cloud or on-premise solution. Its functionality enhances the clinical trial operations from initial planning, implementation, reporting, patient monitoring, and entire documentation. Though data security is a typical challenge for cloud CTMS solution, most third-party providers have most advanced datacenters that require the users accessing the CTMS from outside company’s firewall to go through the authentication process. All the above factors are expected to contribute to sub-segment’s growth over the forecast period.

    North America Captured the Largest Market Share and is Expected to Retain its Dominance

    North America dominated the overall clinical trial management systems market, with the United States emerging as the major contributor to the market. Factors, such as increasing R&D investments and rise in the demand for drug development, are aiding the growth of the market studied in the country. R&D budgets of the pharmaceutical companies have also increased in the last few years, owing to the increasing focus on regulating markets, complex molecules, and therapy segments. In the United States, pharmaceutical companies spend more money, time, and energy on R&D than others. According to, in 2017, 262,433 clinical trials were carried out worldwide, which increased to 285,679 trials in 2018. Whereas, in the United States, 115,123 studies were carried out. Thus, the rise in clinical trials in the region is expected to increase the demand for clinical trial management systems, which, in turn, is expected to aid the growth of the market studied in the United States, over the forecast period.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    The report provides key statistics on the market status of the Clinical Trial Management Systems Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Clinical Trial Management Systems.

    Purchase this Report (Price 4250 USD for single user license) –

    Report Objectives:

    • Analyzing the size of the Clinical Trial Management Systems market on the basis of value and volume.
    • Accurately calculating the market segments, consumption, and other dynamic factors of different sections of the global Clinical Trial Management Systems market.
    • Determining the key dynamics of the Clinical Trial Management Systems market.
    • Highlighting significant trends of the Clinical Trial Management Systems market in terms of manufacture, revenue, and sales.
    • Deeply summarizing top players of the Clinical Trial Management Systems market and showing how they compete in the industry.
    • Studying industry processes and costs, product pricing, and various trends related to them.
    • Displaying the performance of different regions and countries in the global Clinical Trial Management Systems market.

    Detailed TOC of Clinical Trial Management Systems Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Incidences of Chronic Diseases and Lifestyle-related Disorders
    4.2.2 Rise in Outsourcing of Clinical Trials and Implementation by Contract Research Organizations
    4.2.3 Synchronization of Hospital Information System (HIS) with CTMS
    4.3 Market Restraints
    4.3.1 Data Security Issues
    4.3.2 High Cost Associated with CTMS
    4.3.3 Lack of Qualified and Skilled Labor to Handle CTMS
    4.4 Industry Attractiveness- Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Delivery Mode
    5.1.1 Web-based Clinical Trial Management System
    5.1.2 On-premise Clinical Trial Management System
    5.1.3 Cloud-based Clinical Trial Management System
    5.2 By Component
    5.2.1 Software
    5.2.2 Hardware
    5.2.3 Services
    5.3 By End User
    5.3.1 Pharmaceuticals
    5.3.2 Clinical Research Organization
    5.3.3 Other End Users
    5.4 By Type of System
    5.4.1 Site-based Clinical Trial Management System
    5.4.2 Licensed Enterprise-based Clinical Trial Management System
    5.5 Geography
    5.5.1 North America United States Canada Mexico
    5.5.2 Europe United Kingdom Germany France Italy Spain Rest of Europe
    5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.5.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.5.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Bioclinica
    6.1.2 Bio-Optronics Inc.
    6.1.3 DATATRAK International Inc.
    6.1.4 ERT Clinical
    6.1.5 IBM
    6.1.6 Medidata Solutions Inc.
    6.1.7 MedNet Solutions Inc.
    6.1.8 Oracle
    6.1.9 Parexel International Corporation
    6.1.10 ArisGlobal



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Globular Protein Market Share, Size 2019 Developing Rapidly with Recent Trends, Development, Revenue, Demand and Forecast to 2024 | Says Industryresearch.Biz

    Global Renewable Aviation Fuel Market 2019: Industry Size & Share, Business Strategies, Growth Analysis, Regional Demand, Revenue, Key Manufacturers and 2026 Forecast Research Report,

    Industrial Insulation Testers Market 2019-2022 Offers a Detailed Study on Development and Market Trends Adopted by Competitors

    Urothelial Cancer Drugs Market 2019 Explosive Factors of Revenue by Key Vendors Size, Demand, Development Strategy, Future Trends and Industry Growth Research Report

  • Avatar